Last update 13 Nov 2024

GMCN-508B

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
CD34+ haematopoietic stem cells transduced with LentiRed (Genmedicn Biopharma), GMCN508B
Target-
Mechanism
Cell replacements
Therapeutic Areas
Hemic and Lymphatic Diseases
Active Indication
Transfusion-dependent Beta ThalassemiaTransfusion-dependent Thalassemia
Inactive Indication-
Originator Organization
Genmedicn Biopharma Inc.Genmedicn Biopharma Inc.
Active Organization
First Affiliated Hospital of Guangxi Medical UniversityFirst Affiliated Hospital of Guangxi Medical UniversityGenmedicn Biopharma Inc.Genmedicn Biopharma Inc.
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with GMCN-508B
NCT05762510 / RecruitingEarly Phase 1IIT
An Open Label Study Evaluating the Safety and Efficacy of Gene Therapy for Transfusion-dependent β-Thalassemia by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a LentiRed Lentiviral Vector (GMCN-508B Drug Product, Also Called LentiRed)
100 Clinical Results associated with GMCN-508B
Login to view more data
100 Translational Medicine associated with GMCN-508B
Login to view more data
100 Patents (Medical) associated with GMCN-508B
Login to view more data
100 Deals associated with GMCN-508B
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Transfusion-dependent Beta ThalassemiaPhase 1
CN
First Affiliated Hospital of Guangxi Medical UniversityFirst Affiliated Hospital of Guangxi Medical University
22 Feb 2023
Transfusion-dependent Beta ThalassemiaPhase 1
CN
Genmedicn Biopharma Inc.Genmedicn Biopharma Inc.
22 Feb 2023
Transfusion-dependent ThalassemiaPhase 1
CN
First Affiliated Hospital of Guangxi Medical UniversityFirst Affiliated Hospital of Guangxi Medical University
22 Feb 2023
Transfusion-dependent ThalassemiaPhase 1
CN
Genmedicn Biopharma Inc.Genmedicn Biopharma Inc.
22 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free